CytoMed Therapeutics Limited Ordinary Shares · Healthcare · Pharmaceutical Products
As of 2026-06-25, CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 48 (Neutral). Sector: Healthcare. Average daily range 8.2%, relative volume 0.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
35 is not yet a leadership-grade RS read, Market Stance is 48
Daily range, ATR, beta, and the math for a 1-ADR stop.
GDTC is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.2% / -29.8%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GDTC Jan avg: -29.90% median: -27.76% win: 0% σ: 8.81% n: 3 2023-04-17 → 2026-05-29 | GDTC Feb avg: -1.09% median: 6.06% win: 67% σ: 39.05% n: 3 2023-04-17 → 2026-05-29 | GDTC Mar avg: -7.19% median: -7.41% win: 33% σ: 15.05% n: 3 2023-04-17 → 2026-05-29 | GDTC Apr avg: -2.66% median: -1.53% win: 25% σ: 10.32% n: 4 2023-04-17 → 2026-05-29 | GDTC May avg: -0.22% median: 0.13% win: 50% σ: 14.76% n: 4 2023-04-17 → 2026-05-29 | GDTC Jun avg: 1.67% median: -3.02% win: 33% σ: 8.71% n: 3 2023-04-17 → 2026-05-29 (current) | GDTC Jul avg: 4.40% median: -12.98% win: 33% σ: 33.15% n: 3 2023-04-17 → 2026-05-29 | GDTC Aug avg: -11.36% median: -18.16% win: 33% σ: 15.60% n: 3 2023-04-17 → 2026-05-29 | GDTC Sep avg: 3.03% median: 3.69% win: 67% σ: 3.34% n: 3 2023-04-17 → 2026-05-29 | GDTC Oct avg: 23.54% median: 10.55% win: 100% σ: 26.02% n: 3 2023-04-17 → 2026-05-29 | GDTC Nov avg: -6.64% median: -2.49% win: 0% σ: 8.45% n: 3 2023-04-17 → 2026-05-29 | GDTC Dec avg: 16.68% median: 32.79% win: 67% σ: 38.67% n: 3 2023-04-17 → 2026-05-29 |